Effect of Taping in the Hemiplegic Patient With a Deficit of the Footbrowers

Hemiplegia Clinical Trial

— NEUROTAP  

Official title:

A Pilot Study of the Effect of Taping in the Hemiplegic Patient With a Deficit of the Footbrowers

Clinical Trial Details — Status: Terminated

Administrative data

• NCT number: NCT03284606
• Other study ID #: RC31/15/7839
• Secondary ID: 2016-A01552-49
• Status: Terminated
• Phase: N/A
• Start date: September 1, 2017
• Est. completion date: December 31, 2021

Study information

• Verified date: June 2022
• Source: University Hospital, Toulouse
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

A majority of people undergoing rehabilitation following a stroke have a deficit of the dorsal flexors of the foot. The implementation of rehabilitation techniques in accordance with the recommendations of learned societies is not sufficient to compensate for this deficit. Also Kinesio Taping's method of Dr. Kenzo Kase has caught our attention by its action on muscle, joint, circulatory and pain functions.

The use of taping would increase the duration of stimulation of the muscles of the dorsiflexors of the foot which would facilitate the motor recovery.

Data from the literature do not support the conclusion that taping is effective, but no studies evaluating the efficacy of this technique in the foot-lift deficiency of the hemiplegic patient have been found.

The investigators hypothesize that the use of taping in conjunction with common rehabilitation for hemiplegic patients following a stroke improves the stimulation of the muscles of the dorsiflexors of the foot with a positive impact on the walking.

Recruitment information / eligibility

• Status: Terminated
• Enrollment: 7
• Est. completion date: December 31, 2021
• Est. primary completion date: December 31, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• Patient with a stroke occurring in a period ranging from 15 days to a month before inclusion and presenting left or right hemiplegia.

• Voluntary motricity of the dorsal flexors of the foot greater than or equal to 1 on the scale of Held and Pierrot Deseilligny

• Quadriceps voluntary motor skill greater than or equal to 2 on the scale of Held and Pierrot Deseilligny

• Informed consent of the patient.

Exclusion Criteria:

• - Evolutive neurological disease leading to cognitive impairment (Alzheimer's, Parkinson's, Multiple sclerosis ...)

• Pre-stroke neurological sequelae

• Achilles tendon elongation or tendinous transfer surgery.

• Spasticity of the sural triceps greater than 2 on the modified Ashworth scale

• Injection of botulinum toxin

• Patients under guardianship, curatorships or under safeguard of justice.

• Allergy to glue, skin lesions located on the zone of laying of the bands

• Complex Regional Pain Symptom of the Ankle

Related Conditions & MeSH terms

• Hemiplegia

Intervention

Device:
• TAPING
Taping in conjunction with common rehabilitation for hemiplegic patients

Procedure:
• Common rehabilitation
Common rehabilitation for hemiplegic patients

Locations

Country	Name	City	State
France	University Hospital Toulouse	Toulouse

Sponsors (2)

Lead Sponsor	Collaborator
University Hospital, Toulouse	Groupement Interrégional de Recherche Clinique et d'Innovation

Country where clinical trial is conducted

France, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	voluntary muscularity	voluntary muscularity measured by the quotation of Held and Pierrot Deseilligny	Week 10
Secondary	Spasticity score	Ashworth scale modified for spasticity	Week 10